Cargando…

Salicylato[tris­(N-methyl­benzimidazol-2-ylmeth­yl)amine]zinc(II) perchlorate dimethyl­formamide sesquisolvate

In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris­(N-methyl­benzimidazol-2-ylmeth­yl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huilu, Yun, Ruirui, Ding, Jian, Yuan, Jingkun
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915077/
https://www.ncbi.nlm.nih.gov/pubmed/21200485
http://dx.doi.org/10.1107/S1600536807064902
Descripción
Sumario:In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris­(N-methyl­benzimidazol-2-ylmeth­yl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), with approximate mol­ecular C (3) symmetry. One dimethyl­formamide mol­ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl­formamide mol­ecule is disordered about a twofold rotation axis.